RL

Rami Levin

President & Chief Executive Officer

CNS Pharmaceuticals

Therapeutic Areas

CNS Pharmaceuticals Pipeline

DrugIndicationPhase
TPI-287 (Abeotaxane)Recurrent Glioblastoma, Neuroblastoma, Medulloblastoma, Refractory Prostate Cancer, Tauopathy Disease (Dementia)Phase 2
BerubicinGlioblastomaPhase 2/3